Lung abscess differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
Line 138: | Line 138: | ||
! colspan="9" |Clinical features | ! colspan="9" |Clinical features | ||
Signs & symptoms | Signs & symptoms | ||
! rowspan="3" |Characterstic feature | ! rowspan="3" |Characterstic feature | ||
|- | |- | ||
Line 164: | Line 163: | ||
| | | | ||
| | | | ||
| | | | ||
* Purulent sputum | * Purulent sputum | ||
Line 182: | Line 179: | ||
|✔ | |✔ | ||
|✔ | |✔ | ||
| | | | ||
* Chronic smoker | * Chronic smoker | ||
Line 202: | Line 197: | ||
| | | | ||
|✔ | |✔ | ||
| | | | ||
* People in endemic at high risk | * People in endemic at high risk | ||
Line 219: | Line 212: | ||
| | | | ||
| | | | ||
| | | | ||
* Acute life threatening condition | * Acute life threatening condition | ||
Line 238: | Line 229: | ||
| | | | ||
| | | | ||
| | | | ||
* CBC positive for causative agent. | * CBC positive for causative agent. | ||
Line 253: | Line 242: | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
Line 271: | Line 254: | ||
| | | | ||
| | | | ||
| | | | ||
* Seen mostly in Female age group of 40-55 years | * Seen mostly in Female age group of 40-55 years | ||
Line 290: | Line 271: | ||
|✔ | |✔ | ||
|✔ | |✔ | ||
| | | | ||
* More common in African-american females | * More common in African-american females | ||
Line 307: | Line 286: | ||
|✔ | |✔ | ||
| | | | ||
| | | | ||
* Seen in patients with rheumatoid arthritis | * Seen in patients with rheumatoid arthritis | ||
Line 323: | Line 300: | ||
|✔ | |✔ | ||
| | | | ||
| | | | ||
* Exclusively afflicts smokers, with a peak age of onset of between 20 and 40 years. | * Exclusively afflicts smokers, with a peak age of onset of between 20 and 40 years. | ||
Line 340: | Line 315: | ||
| | | | ||
| | | | ||
| | | | ||
* Mimics [[asthma]], [[pneumonia]] and [[emphysema]] | * Mimics [[asthma]], [[pneumonia]] and [[emphysema]] |
Revision as of 20:17, 8 February 2017
Lung abscess Microchapters |
Diagnosis |
Treatment |
Case Studies |
Lung abscess differential diagnosis On the Web |
American Roentgen Ray Society Images of Lung abscess differential diagnosis |
Risk calculators and risk factors for Lung abscess differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Lung abscess must be differentiated from other lesions that present with similar symptoms such as cough, fever with chills and rigor and chest includes malignancy, pulmonary tuberculosis, Wegener's granulomatosis, rheumatoid nodules.
Differential diagnosis
Causes of
lung cavities |
Differentiating Features | Differentiating lab findings | Diagnosis
confirmation |
---|---|---|---|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
||
|
|
| |
|
|
|
Disease | Clinical features
Signs & symptoms |
Characterstic feature | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Fever | Cough | Hemoptysis | Dyspnea | Chest pain | Weight loss | Night sweats | ||||
High-grade | Low grade | Productive | Dry | |||||||
Acute Lung abscess | ✔ | ✔ | ✔ |
| ||||||
Malignancy
(primary lung cancer) |
✔ | ✔ | ✔ | ✔ | ✔ |
| ||||
Pulmonary Tuberculosis | ✔ | ✔ | ✔ | ✔ |
| |||||
Necrotizing Pneumonia | ✔ | ✔ | ✔ | ✔ |
| |||||
Pneumonia and empyema | ✔ | ✔ | ✔ | ✔ | ✔ |
| ||||
Bronchiectasis | ✔ | ✔ | ||||||||
Wegners granulomatosis | ✔ | ✔ | ✔ |
| ||||||
Sarcoidosis | ✔ | ✔ | ✔ | ✔ | ✔ |
| ||||
Rheumatoid nodule | ✔ | ✔ |
| |||||||
Langerhans cell Histiocytosis | ✔ | ✔ | ✔ |
| ||||||
Bronchiolitis obliterans | ✔ | ✔ | ✔ | ✔ |
Reference
- ↑ 1.0 1.1 Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
- ↑ Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
- ↑ Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM (2005). "Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome". Radiology. 237 (1): 342–7. doi:10.1148/radiol.2371041650. PMID 16183941.
- ↑ 4.0 4.1 Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
- ↑ Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, Ashizawa K, Johkoh T, Kim EA, Kwon OJ (2003). "Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients". Eur Radiol. 13 (1): 43–51. doi:10.1007/s00330-002-1422-2. PMID 12541109.
- ↑ Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001). "Clinical characteristics of patients in a case control study of sarcoidosis". Am. J. Respir. Crit. Care Med. 164 (10 Pt 1): 1885–9. doi:10.1164/ajrccm.164.10.2104046. PMID 11734441.
- ↑ Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H (1989). "Pulmonary sarcoidosis: evaluation with high-resolution CT". Radiology. 172 (2): 467–71. doi:10.1148/radiology.172.2.2748828. PMID 2748828.
- ↑ Murphy J, Schnyder P, Herold C, Flower C (1998). "Bronchiolitis obliterans organising pneumonia simulating bronchial carcinoma". Eur Radiol. 8 (7): 1165–9. doi:10.1007/s003300050527. PMID 9724431.
- ↑ 9.0 9.1 Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN (2008). "Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review". Ann Thorac Med. 3 (2): 67–75. doi:10.4103/1817-1737.39641. PMC 2700454. PMID 19561910.
- ↑ Cordier JF, Loire R, Brune J (1989). "Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients". Chest. 96 (5): 999–1004. PMID 2805873.
- ↑ Lee KS, Kullnig P, Hartman TE, Müller NL (1994). "Cryptogenic organizing pneumonia: CT findings in 43 patients". AJR Am J Roentgenol. 162 (3): 543–6. doi:10.2214/ajr.162.3.8109493. PMID 8109493.
- ↑ Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.
- ↑ Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR (1989). "Pulmonary histiocytosis X: comparison of radiographic and CT findings". Radiology. 172 (1): 249–54. doi:10.1148/radiology.172.1.2787035. PMID 2787035.